These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36652757)

  • 1. Decreased expression of ADAM10 on monocytes is associated with chronic allograft dysfunction in kidney transplant recipients.
    Li Y; Bai Y; Zhang H; Li Y; Yan L; Wang X; Fan J; An Y; Wan Z; Hu S; Wang L; Shi Y
    Int Immunopharmacol; 2023 Feb; 115():109710. PubMed ID: 36652757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Tim-3 and Gal-9 are associated with renal allograft dysfunction in kidney transplant recipients: A cross-sectional study.
    Li YM; Shi YY; Li Y; Yan L; Tang JT; Bai YJ; Wu XJ; Dai B; Zou YG; Wang LL
    Int Immunopharmacol; 2018 Feb; 55():330-335. PubMed ID: 29310109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma soluble Tim-3 emerges as an inhibitor in sepsis: sepsis contrary to membrane Tim-3 on monocytes.
    Ren F; Li J; Jiang X; Xiao K; Zhang D; Zhao Z; Ai J; Hou C; Jia Y; Han G; Xie L
    Tissue Antigens; 2015 Nov; 86(5):325-32. PubMed ID: 26373631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression.
    Clayton KL; Douglas-Vail MB; Nur-ur Rahman AK; Medcalf KE; Xie IY; Chew GM; Tandon R; Lanteri MC; Norris PJ; Deeks SG; Ndhlovu LC; Ostrowski MA
    J Virol; 2015 Apr; 89(7):3723-36. PubMed ID: 25609823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered Serum Bile Acid Profile Associated with Chronic Allograft Dysfunction in Kidney Transplant Recipients.
    Li Y; Zhang H; Dai X; An Y; Li Y; Yan L; Shi Y; Fan J; Gong X; Zhang L; Zou Y; Wang L; Bai Y
    Ann Transplant; 2022 Nov; 27():e937974. PubMed ID: 36397663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell immunoglobulin and mucin domain 2 (TIM-2) is a target of ADAM10-mediated ectodomain shedding.
    Dewitz C; Möller-Hackbarth K; Schweigert O; Reiss K; Chalaris A; Scheller J; Rose-John S
    FEBS J; 2014 Jan; 281(1):157-74. PubMed ID: 24164679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble T cell immunoglobulin and mucin domain (TIM)-1 and -4 generated by A Disintegrin And Metalloprotease (ADAM)-10 and -17 bind to phosphatidylserine.
    Schweigert O; Dewitz C; Möller-Hackbarth K; Trad A; Garbers C; Rose-John S; Scheller J
    Biochim Biophys Acta; 2014 Feb; 1843(2):275-87. PubMed ID: 24286866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.
    Buchanan PC; Boylan KLM; Walcheck B; Heinze R; Geller MA; Argenta PA; Skubitz APN
    J Biol Chem; 2017 Apr; 292(15):6339-6351. PubMed ID: 28232483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3).
    Möller-Hackbarth K; Dewitz C; Schweigert O; Trad A; Garbers C; Rose-John S; Scheller J
    J Biol Chem; 2013 Nov; 288(48):34529-44. PubMed ID: 24121505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human and Murine Interleukin 23 Receptors Are Novel Substrates for A Disintegrin and Metalloproteases ADAM10 and ADAM17.
    Franke M; Schröder J; Monhasery N; Ackfeld T; Hummel TM; Rabe B; Garbers C; Becker-Pauly C; Floss DM; Scheller J
    J Biol Chem; 2016 May; 291(20):10551-61. PubMed ID: 26961870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.
    Urriola-Muñoz P; Li X; Maretzky T; McIlwain DR; Mak TW; Reyes JG; Blobel CP; Moreno RD
    J Cell Physiol; 2018 Mar; 233(3):2247-2256. PubMed ID: 28703301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradome of soluble ADAM10 and ADAM17 metalloproteases.
    Scharfenberg F; Helbig A; Sammel M; Benzel J; Schlomann U; Peters F; Wichert R; Bettendorff M; Schmidt-Arras D; Rose-John S; Moali C; Lichtenthaler SF; Pietrzik CU; Bartsch JW; Tholey A; Becker-Pauly C
    Cell Mol Life Sci; 2020 Jan; 77(2):331-350. PubMed ID: 31209506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
    Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
    Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The collectrin-like part of the SARS-CoV-1 and -2 receptor ACE2 is shed by the metalloproteinases ADAM10 and ADAM17.
    Niehues RV; Wozniak J; Wiersch F; Lilienthal E; Tacken N; Schumertl T; Garbers C; Ludwig A; Düsterhöft S
    FASEB J; 2022 Mar; 36(3):e22234. PubMed ID: 35199397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gut-Brain Axis in Autism Spectrum Disorder: A Focus on the Metalloproteases ADAM10 and ADAM17.
    Zheng Y; Verhoeff TA; Perez Pardo P; Garssen J; Kraneveld AD
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of a disintegrin and metalloproteinase (ADAM)10 and ADAM17 in the pathogenesis of psoriasis.
    Gül C; Kilic S; Şehitoğlu MH
    Clin Exp Dermatol; 2022 Sep; 47(9):1673-1678. PubMed ID: 35474465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro Evaluation of ADAM10 and ADAM17 Highly Selective Bioimaging Probes.
    Camodeca C; Nuti E; Tosetti F; Poggi A; D'Arrigo C; Zocchi MR; Rossello A
    ChemMedChem; 2018 Oct; 13(19):2119-2131. PubMed ID: 30102846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage Site Localization Differentially Controls Interleukin-6 Receptor Proteolysis by ADAM10 and ADAM17.
    Riethmueller S; Ehlers JC; Lokau J; Düsterhöft S; Knittler K; Dombrowsky G; Grötzinger J; Rabe B; Rose-John S; Garbers C
    Sci Rep; 2016 May; 6():25550. PubMed ID: 27151651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of ADAM17 and ADAM10 in nasal polyps.
    Bae WY; Park SK; Kim do H; Koh TK; Hur DY; Chueh HW
    Int Forum Allergy Rhinol; 2016 Jul; 6(7):731-6. PubMed ID: 27012683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ADAM10 and ADAM17 in Regulating CD137 Function.
    Seidel J; Leitzke S; Ahrens B; Sperrhacke M; Bhakdi S; Reiss K
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.